Home » Newsletters » BioWorld MedTech » Archive

BioWorld MedTech Archive Index

Choose an Issue

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 30, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 30, 2024.
Corbus rockets on early clinical data for next-gen Nectin-4 ADC candidate
BioWorld
Shares of Corbus Pharmaceuticals Inc. (NASDAQ:CRBP) doubled on opening Jan. 26 and ended the day up a whopping 249% as investors got a look at data from a...
Following JPM, 2024 outlook ranges from hopeful to cautious
BioWorld
Setting the tone for the biopharma industry as it enters a new year, the J.P. Morgan Healthcare Conference (JPM) held each January has once again led to...
Tempest Therapeutics presents new TREX1 inhibitors for cancer
BioWorld Science
Tempest Therapeutics Inc. has divulged three-prime repair exonuclease 1 (TREX1) inhibitors reported to be useful for the treatment of cancer.

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Subscribe

BioWorld MedTech Archive Index

2024

2023

2022

2021

2020

2019

2018

2017

2016

2015

2014

2013

2012